News Releases

Below please read about some of the latest news from Standex. Also, please read about other goings-on by visiting our Brands tab and visiting our five product segments.

To subscribe to our newsfeeds, please visit our "Investors" tab.

Standex Reports Fiscal Second Quarter 2022 Financial Results

  • Consolidated Organic Revenue Growth of Approximately 20% Year-Over-Year with Record Sales at Electronics and Scientific Segments Supported by Market Share Gains
  • GAAP Operating Margin Increased 100 Basis Points Year-Over-Year and Adjusted Operating Margin Increased 220 Basis Points Year-Over -Year Driven by Sales Growth and Productivity Initiatives
  • Solid Cash Flow Generation Further Reinforcing Strong Balance Sheet and Liquidity Position
  • Expect Continued Improvement in Financial Performance in the Second Half of Fiscal 2022; Well positioned to exceed our prior long-term outlook of mid-single digit organic revenue growth

SALEM, N.H.Feb. 3, 2022 /PRNewswire/ — Standex International Corporation (NYSE:SXI) today reported financial results for the second quarter of fiscal year 2022 ending December 31, 2021.

 Summary Financial Results – Total Standex

($M except EPS and Dividends)

2Q22

2Q21

1Q22

Y/Y

Q/Q

Net Sales

$185.7

$156.3

$175.6

18.8%

5.8%

Operating Income – GAAP

$21.8

$16.7

$22.8

30.1%

-4.6%

Operating Income – Adjusted

$25.2

$17.8

$23.5

41.7%

7.5%

Operating Margin – GAAP

11.7%

10.7%

13.0%

+100 bps

-130 bps

Operating Margin – Adjusted

13.6%

11.4%

13.4%

+220 bps

+20 bps

Net Income from Continuing Ops – GAAP

$15.0

$12.0

$15.8

25.2%

-5.0%

Net Income from Continuing Ops – Adjusted

$17.6

$12.9

$16.3

37.2%

8.1%

EBITDA

$29.0

$25.1

$30.5

15.3%

-5.1%

EBITDA margin

15.6%

16.1%

17.4%

-50 bps

-180 bps

Adjusted EBITDA

$32.5

$26.2

$31.2

23.8%

4.1%

Adjusted EBITDA margin

17.5%

16.8%

17.8%

+70 bps

-30 bps

Diluted EPS – GAAP

$1.24

$0.98

$1.30

26.5%

-4.6%

Diluted EPS – Adjusted

$1.45

$1.05

$1.34

38.1%

8.2%

Dividends per share

$0.26

$0.24

$0.24

8.3%

8.3%

Free Cash Flow

$18.9

$17.0

$8.1

11.6%

134.5%

Net Debt to EBITDA

0.4x

0.9x

0.6x

-54.8%

-27.6%

 

 

Second Quarter Fiscal 2022 Results 

Commenting on the quarter’s results, President and Chief Executive Officer David Dunbar said, “We are very pleased with our strong second quarter performance, which was above our expectations with record quarterly sales in both the Electronics and Scientific segments, as we delivered significant organic growth and strong consolidated adjusted operating margin in the quarter.  We continue to see the benefit of our ongoing productivity and efficiency initiatives which also results in further strengthening of our financial flexibility. We are excited about the new business opportunities in front of us and are very well-positioned to further execute on our growth strategy given our healthy order trends, consistent cash flow generation and portfolio of high-quality businesses.

Order trends in our end markets remain favorable with broad-based demand growth and market share gains, particularly in high growth markets. Total company backlog realizable in under one year increased approximately 11% sequentially and 53% compared to fiscal second quarter 2021 with strength particularly at the Electronics, Specialty Solutions, and Scientific segments. We are also progressing our work on a solar power project with a global energy company and expect to move to a pilot plant phase by calendar year-end. As a result, we are well positioned to exceed our prior long-term revenue outlook of mid-single digit organic growth.

Despite the challenging operating environment, our approach globally remains highly collaborative and well-coordinated, as we continue to drive cost management through manufacturing and supply chain productivity initiatives together with price realization actions.  Consolidated adjusted operating margin of 13.6% in fiscal second quarter 2022 represented a 220 basis points increase year-over-year and 20 basis points improvement sequentially.  In addition, the Electronics segment remains on track to substantially complete our reed switch production and material substitution project by the end of fiscal 2022.

“Our financial profile also further strengthened in the second quarter, positioning us well to invest in a very active pipeline of organic and inorganic growth opportunities. The Company had approximately $281 million in available liquidity and a net debt to adjusted EBITDA ratio of approximately 0.42x at the end of the fiscal second quarter 2022. We also generated free operating cash flow of approximately $18.9 million in the quarter, an 11.6% increase year-over-year, reflecting improvement in working capital metrics.

“In the second half of fiscal 2022, we expect to continue to build on current momentum and deliver improved results both year-over-year and compared to first half of fiscal 2022. Our business portfolio is increasingly aligned with sustainable global growth trends across a diverse group of end markets including electric vehicles, renewable energy, space commercialization and smart grid. In addition, we are also further leveraging our market positions and deep technical and applications expertise through highly targeted investment in research and development, expanding our base of innovative solutions and compelling customer value propositions,” concluded Dunbar.

Outlook

In fiscal third quarter 2022, the Company expects revenue to be similar to slightly higher and operating margin to be slightly higher on a sequential basis and significantly higher compared to fiscal third quarter 2021.

Compared to fiscal second quarter 2022, the Company expects that the Specialty Solutions and Electronics segments will be the primary drivers of revenue increase.   This growth is expected to be balanced by a moderate revenue decrease at the Scientific segment due to anticipated lower demand following record sales in the second quarter. Revenue at Engineering Technologies is expected to be sequentially similar to slightly higher with Engraving revenue similar to fiscal second quarter 2022 sales.

Second Quarter Segment Operating Performance

Electronics (41% of sales; 51% of segment operating income)

2Q22

2Q21

% Change

Electronics ($M)

Revenue

$76.6

$60.2

27.4%

Operating Income

17.2

10.0

72.2%

Operating Margin

22.4%

16.6%

 

Revenue increased approximately $16.4 million or 27.4% year-over-year reflecting a 27.9% organic growth rate partially offset by an approximate 0.5% impact from foreign exchange.  Organic revenue growth was due to continued broad-based end market strength including increased demand for relays in renewable energy and electric vehicle applications as well as the impact of pricing actions.

Operating income increased approximately $7.2 million or 72.2% year-over-year which reflected operating leverage associated with revenue growth, pricing, and productivity actions.

In fiscal third quarter 2022, the Company expects a slight sequential increase in revenue and operating margin reflecting continued positive end market demand trends and associated operating leverage.  Year-over-year, the Company expects revenue and operating margin to increase significantly compared to fiscal third quarter 2021.

Engraving (20% of sales; 15% of segment operating income)

2Q22

2Q21

% Change

Engraving ($M)

Revenue

$36.6

$38.0

-3.4%

Operating Income

5.2

6.5

-20.0%

Operating Margin

14.2%

17.1%

Revenue and operating income both decreased year-over-year approximately $1.3 million or 3.4% and 20.0% respectively, reflecting the timing of projects and geographic mix.   In fiscal third quarter 2022, the Company expects sales and operating margin to be sequentially similar due to a decrease in project work in Asia, associated with the Chinese New Year, offset by contribution from projects in Europe and growth in soft trim sales.

Scientific (13% of sales; 16% of segment operating income)

2Q22

2Q21

% Change

Scientific ($M)

Revenue

$24.6

$17.9

37.7%

Operating Income

5.5

4.2

29.7%

Operating Margin

22.3%

23.7%

Revenue increased approximately $6.7 million or 37.7% year-over-year reflecting positive trends in pharmaceutical, clinical laboratories, and academic institution end markets complemented by ongoing strong demand for COVID-19 vaccine storage.  Operating income increased approximately $1.3 million or 29.7% year-over-year, reflecting the volume increase and pricing initiatives balanced with investments to support future growth opportunities and higher freight costs.

In fiscal third quarter 2022, the Company expects a moderate decrease in revenue and operating margin compared to fiscal second quarter 2022 reflecting lower volume.  Fiscal second quarter 2022 represented the highest quarterly sales in the Scientific segment’s history.

Engineering Technologies (10% of sales; 7% of segment operating income)

2Q22

2Q21

% Change

Engineering Technologies ($M)

Revenue

$18.1

$17.5

3.4%

Operating Income

2.3

1.4

69.8%

Operating Margin

12.8%

7.8%

Revenue increased $0.6 million or 3.4% year-over-year reflecting continued recovery in commercial aviation demand and growth in power generation end markets offset by the absence of the recently divested Enginetics business.  Enginetics contributed approximately $2.3 million in revenue to fiscal second quarter 2021.

Operating income increased approximately $0.9 million or 69.8% primarily reflecting recovery in commercial aviation end markets and the absence of the divested Enginetics business.

In fiscal third quarter 2022, the Company expects revenue to be sequentially similar to slightly higher with a slight to moderate increase in operating margin.  This outlook reflects growth in space and medical end markets and the impact of productivity initiatives.

Specialty Solutions (16% of sales; 11% of segment operating income)

2Q22

2Q21

% Change

Specialty Solutions ($M)

Revenue

$29.7

$22.8

30.4%

Operating Income

3.7

3.2

16.4%

Operating Margin

12.6%

14.1%

On a year-over-year basis, Specialty Solutions revenue increased approximately $6.9 million or 30.4% and operating income increased $0.5 million or 16.4%.  Fiscal second quarter 2022 results reflected positive trends in food service, specialty retail, and refuse end markets.  These results were balanced with material inflation and increased freight costs which the Company is seeking to recover through pricing actions.

In fiscal third quarter 2022, the Company expects a slight to moderate increase in revenue and operating margin compared to fiscal second quarter 2022 reflecting execution on a solid backlog position.

Capital Allocation

  • Capital Expenditures: In fiscal second quarter 2022, Standex’s capital expenditures were $4.7 million compared to $5.3 million in the fiscal second quarter of 2021.  Investments were focused on maintenance, safety, and the Company’s highest priority growth initiatives.  The Company expects fiscal year 2022 capital expenditures between $25 million and $30 million.
  • Dividends:  On January 27, 2022, the Company declared a quarterly cash dividend of $0.26 per share, an approximately 8.3% year-over-year increase.  The dividend is payable on February 25, 2022, to shareholders of record on February 11, 2022.

Balance Sheet and Cash Flow Highlights

  • Net Debt: Standex had net debt of $52.5 million at December 31, 2021 compared to $63.1 million at the end of fiscal 2021 and $90.9 million at the end of fiscal second quarter 2021.  Net debt for the first quarter of 2022 consisted primarily of long-term debt of approximately $200 million and cash and equivalents of $147 million of which approximately $100 million was held by foreign subsidiaries. The Company’s net debt to adjusted EBITDA leverage ratio was approximately 0.42x at the end of the fiscal second quarter 2022.
  • Cash Flow:  Net cash provided by continuing operating activities for the three months ended December 31, 2021 was $23.6 million compared to net cash provided by continuing operating activities of $22.3 million in the prior year. The Company generated free cash flow after capital expenditures of $18.9 million compared to free cash flow after capital expenditures of $17.0 million in the fiscal second quarter of 2021.

Conference Call Details

Standex will host a conference call for investors tomorrow, February 4, 2022, at 8:30 a.m. ET. On the call, David Dunbar, President and CEO, and Ademir Sarcevic, CFO, will review the Company’s financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the “Investors” section of Standex’s website under the subheading, “Events and Presentations,” located at www.standex.com.

A replay of the webcast will also be available on the Company’s website shortly after the conclusion of the presentation online through February 4, 2023. To listen to the teleconference playback, please dial (877)-344-7529 in the U.S. or (412)- 317-0088 internationally; the passcode is 5716190.  The audio playback via phone will be available through February 11, 2022. The webcast replay can be accessed in the “Investor Relations” section of the Company’s website, located at www.standex.com.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles (“GAAP”), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures including the impact of restructuring charges, purchase accounting, insurance recoveries, discrete tax events, loss on sale of a business unit, and acquisition costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company’s performance, especially when comparing such results to previous periods.  An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.  Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United StatesEuropeCanadaJapanSingaporeMexicoBrazilTurkeySouth AfricaIndia and China.  For additional information, visit the Company’s website at http://standex.com/.

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue, or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Companys business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics such as the current coronavirus on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; and potential changes to future pension funding requirements. In addition, any forward-looking statements represent management’s estimates only as of the day made and should not be relied upon as representing management’s estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management’s estimates change.

Standex International Corporation

Consolidated Statement of Operations

(unaudited)

Three Months Ended

Six Months Ended

December 31,

December 31,

(In thousands, except per share data)

2021

2020

2021

2020

Net sales

$

185,709

$

156,283

$

361,319

$

307,569

Cost of sales

116,937

98,267

226,310

194,816

Gross profit

68,772

58,016

135,009

112,753

Selling, general and administrative expenses

43,531

40,199

86,283

79,069

Restructuring costs

843

509

1,283

1,996

Acquisition related costs

925

570

1,142

596

Other operating (income) expense, net

1,700

1,700

Income from operations

21,773

16,738

44,601

31,092

Interest expense

1,526

1,601

3,246

3,086

Other non-operating (income) expense, net

288

(60)

311

(231)

Total

1,814

1,541

3,557

2,855

Income from continuing operations before income taxes

19,959

15,197

41,044

28,237

Provision for income taxes

4,929

3,189

10,193

5,885

Net income from continuing operations

15,030

12,008

30,851

22,352

Income (loss) from discontinued operations, net of tax

(46)

(631)

(49)

(1,258)

Net income

$

14,984

$

11,377

$

30,802

$

21,094

Basic earnings per share:

Income (loss) from continuing operations

$

1.25

$

0.98

$

2.56

$

1.83

Income (loss) from discontinued operations

(0.05)

(0.10)

Total

$

1.25

$

0.93

$

2.56

$

1.73

Diluted earnings per share:

Income (loss) from continuing operations

$

1.24

$

0.98

$

2.54

$

1.82

Income (loss) from discontinued operations

(0.05)

(0.10)

Total

$

1.24

$

0.93

$

2.54

$

1.72

Average Shares Outstanding

   Basic

12,033

12,195

12,028

12,213

   Diluted

12,138

12,270

12,144

12,277

 

 

Standex International Corporation

Condensed Consolidated Balance Sheets

(unaudited)

December 31,

June 30,

(In thousands)

2021

2021

ASSETS

Current assets:

  Cash and cash equivalents

$

147,155

$

136,367

  Accounts receivable, net

107,107

109,883

  Inventories

102,223

91,862

  Prepaid expenses and other current assets

28,869

23,504

  Income taxes receivable

12,025

12,750

    Total current assets

397,379

374,366

Property, plant, equipment, net

129,242

133,373

Intangible assets, net

92,852

98,929

Goodwill

273,760

278,054

Deferred tax asset

7,851

9,566

Operating lease right-of-use asset

37,819

37,276

Other non-current assets

31,667

30,659

    Total non-current assets

573,191

587,857

Total assets

$

970,570

$

962,223

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

  Accounts payable

$

75,254

$

74,756

  Accrued liabilities

53,941

61,717

  Income taxes payable

8,815

7,236

    Total current liabilities

138,010

143,709

Long-term debt

199,660

199,490

Operating lease long-term liabilities

30,114

29,041

Accrued pension and other non-current liabilities

79,336

83,558

    Total non-current liabilities

309,110

312,089

Stockholders’ equity:

  Common stock

41,976

41,976

  Additional paid-in capital

84,560

80,788

  Retained earnings

877,158

852,489

  Accumulated other comprehensive loss

(120,010)

(116,140)

  Treasury shares

(360,234)

(352,688)

     Total stockholders’ equity

523,450

506,425

Total liabilities and stockholders’ equity

$

970,570

$

962,223

 

 

Standex International Corporation and Subsidiaries

Statements of Consolidated Cash Flows

(unaudited)

Six Months Ended

December 31,

(In thousands)

2021

2020

Cash Flows from Operating Activities

Net income

$

30,802

$

21,094

Income (loss) from discontinued operations

(49)

(1,258)

Income from continuing operations

30,851

22,352

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

Depreciation and amortization

15,222

16,521

Stock-based compensation

4,625

4,288

Non-cash portion of restructuring charge

337

(492)

Contributions to defined benefit plans

(104)

(4,880)

Net changes in operating assets and liabilities

(14,232)

(6,281)

Net cash provided by operating activities – continuing operations

36,699

31,508

Net cash provided by (used in) operating activities – discontinued operations

(364)

2,254

Net cash provided by (used in) operating activities

36,335

33,762

Cash Flows from Investing Activities

    Expenditures for property, plant and equipment

(9,721)

(10,145)

    Expenditures for acquisitions, net of cash acquired

(27,398)

    Other investing activities

1,646

275

Net cash (used in) investing activities

(8,075)

(37,268)

Cash Flows from Financing Activities

    Contingent consideration payment

(1,167)

    Activity under share-based payment plans

1,147

971

    Purchase of treasury stock

(9,546)

(7,593)

    Cash dividends paid

(6,019)

(5,624)

Net cash provided by (used in) financing activities

(15,585)

(12,246)

Effect of exchange rate changes on cash

(1,887)

6,053

Net changes in cash and cash equivalents

10,788

(9,699)

Cash and cash equivalents at beginning of year

136,367

118,809

Cash and cash equivalents at end of period

$

147,155

$

109,110

 

 

Standex International Corporation

Selected Segment Data

(unaudited)

Three Months Ended

Six Months Ended

December 31,

December 31,

(In thousands)

2021

2020

2021

2020

Net Sales

Electronics

$

76,626

$

60,156

$

152,462

$

115,427

Engraving

36,644

37,950

71,814

74,351

Scientific

24,636

17,893

46,165

34,556

Engineering Technologies

18,095

17,507

35,668

35,140

Specialty Solutions

29,708

22,777

55,210

48,095

Total

$

185,709

$

156,283

$

361,319

$

307,569

Income from operations

Electronics

$

17,157

$

9,962

$

35,430

$

18,497

Engraving

5,204

6,501

10,078

12,374

Scientific

5,490

4,234

9,998

8,310

Engineering Technologies

2,314

1,363

3,213

1,831

Specialty Solutions

3,738

3,211

6,553

7,117

Restructuring

(843)

(509)

(1,283)

(1,996)

Acquisition related costs

(925)

(570)

(1,142)

(596)

Corporate

(8,662)

(7,454)

(16,546)

(14,445)

Other operating income (expense), net 

(1,700)

(1,700)

Total

$

21,773

$

16,738

$

44,601

$

31,092

 

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

Three Months Ended

Six Months Ended

December 31,

December 31,

(In thousands, except percentages)

2021

2020

% Change

2021

2020

% Change

Adjusted income from operations and adjusted net
income from continuing operations:

Net Sales

$

185,709

$

156,283

18.8%

$

361,319

$

307,569

17.5%

Income from operations, as reported

$

21,773

$

16,738

30.1%

$

44,601

$

31,092

43.4%

Income from operations margin

11.7%

10.7%

12.3%

10.1%

Adjustments:

Restructuring charges

843

509

1,283

1,996

Acquisition-related costs

925

570

1,142

596

Litigation charge

1,700

1,700

Purchase accounting expenses

592

Adjusted income from operations

$

25,241

$

17,817

41.7%

$

48,726

$

34,276

42.2%

Adjusted income from operations margin

13.6%

11.4%

13.5%

11.1%

Interest and other income (expense), net

(1,814)

(1,541)

(3,557)

(2,855)

Provision for income taxes

(4,929)

(3,189)

(10,193)

(5,885)

Discrete and other tax items

(196)

Tax impact of above adjustments

(857)

(226)

(1,021)

(662)

Net income from continuing operations, as adjusted

$

17,641

$

12,862

37.2%

$

33,955

$

24,678

37.6%

EBITDA and Adjusted EBITDA:

Net income (loss) from continuing operations,
as reported

$

15,030

$

12,008

25.2%

$

30,851

$

22,352

Net income from continuing operations margin

8.1%

7.7%

8.5%

7.3%

Add back:

Provision for income taxes

4,929

3,189

10,193

5,885

Interest expense

1,526

1,601

3,246

3,086

Depreciation and amortization

7,497

8,328

15,222

16,521

EBITDA

$

28,982

$

25,126

15.3%

$

59,512

$

47,844

24.4%

EBITDA Margin

15.6%

16.1%

16.5%

15.6%

Adjustments:

Restructuring charges

843

509

1,283

1,996

Acquisition-related costs

925

570

1,142

596

Litigation charge

1,700

1,700

Purchase accounting expenses

592

Adjusted EBITDA

$

32,450

$

26,205

23.8%

$

63,637

$

51,028

24.7%

Adjusted EBITDA Margin

17.5%

16.8%

17.6%

16.6%

Free cash flow:

Net cash provided by operating activities –
continuing operations, as reported

$

23,613

$

22,276

$

36,699

$

31,508

Less: Capital expenditures

(4,699)

(5,325)

(9,721)

(10,145)

Free operating cash flow

$

18,914

$

16,951

$

26,978

$

21,363

 

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

Three Months Ended

Six Months Ended

Adjusted earnings per share from continuing
operations

December 31,

December 31,

2021

2020

%
Change

2021

2020

% Change

Diluted earnings per share from continuing
operations, as reported

$

1.24

$

0.98

26.5%

$

2.54

$

1.82

39.6%

Adjustments:

Restructuring charges

0.05

0.03

0.09

0.13

Acquisition-related costs

0.06

0.04

0.07

0.04

Litigation charge

0.10

0.10

Discrete tax items

(0.02)

Purchase accounting expenses

0.04

Diluted earnings per share from continuing
operations, as adjusted

$

1.45

$

1.05

38.1%

$

2.80

$

2.01

39.3%

 

 

SOURCE Standex International Corporation

For further information: Ademir Sarcevic, CFO, (603) 893-9701, e-mail : InvestorRelations@Standex.com